Translational immunologic safety evaluation: A perspective

References

• Bilitewski, U. 2008. Determination of immunomodulatory effects: Focus on functional analysis of phagocytes as representatives of the innate immune system. Anal. Bioanal. Chem. 391:1545–1554.
   PubMedGoogle Scholar
• Brockow, K., Romano, A. 2008. Skin tests in the diagnosis of drug hypersensitivity reactions. Curr. Pharm. Res. 14:2778–2791.
   PubMed Web of Science ®Google Scholar
• Bugelski, P. J., Kim, C. 2007. T-Dependent antigen response (TDAR) tests: Meta-analysis of results generated across multiple laboratories. J. Immunotoxicol. 4:159–164.
   PubMed Web of Science ®Google Scholar
• Burchiel, S. W., Lauer, F. T., Gurule, D., Mounho, B. J., Salas, V. M. 1999. Uses and future applications of flow cytometry in immunotoxicity testing. Methods 19:28–35.
   PubMed Web of Science ®Google Scholar
• Cederbrant, K., Marcusson-Ståhl, M., Condevaux, F., Descotes, J. 2003. NK-cell activity in immunotoxicity drug evaluation. Toxicology 185:241–250.
   PubMed Web of Science ®Google Scholar
• Callahan, M. K., Wolchok, J. D., Allison, J. P. 2010. Anti-CTLA-4 antibody therapy: Immune monitoring during clinical development of a novel immunotherapy. Semin. Oncol. 37:473–484.
   PubMed Web of Science ®Google Scholar
• Cordoba, F., Wieczorek, G., Preussing, E., Bigaud M. 2008. Modeling of delayed-type hypersensitivity (DTH) in the non-human primate (NHP). Drug Discov. Today Anim. Models 5:63–71.
   Google Scholar
• Corsini, E., House, R. V. 2010. Evaluating cytokines in immunotoxicity testing. Meth. Mol. Biol. 598:283–302.
   PubMedGoogle Scholar
• Cox, J. H., Ferrari, G., Janetzki, S. 2006. Measurement of cytokine release at the single cell level using the ELISPOT assay. Methods 38:274–282.
   PubMed Web of Science ®Google Scholar
• Descotes, J. 2004. Importance of immunotoxicity in safety assessment: A medical toxicologist’s point of view. Toxicol. Lett. 149:103–108.
   PubMed Web of Science ®Google Scholar
• Descotes, J. 2006. Methods of evaluating immunotoxicity. Expert Opin. Drug Metab. Toxicol. 2:249–259.
   PubMed Web of Science ®Google Scholar
• Descotes, J., Nicolas, B., Vial, T., Nicolas, J. F. 1996. Biomarkers of immunotoxicity in man. Biomarkers 1:77–80.
   PubMed Web of Science ®Google Scholar
• Descotes, J., Tedone, R., Evreux, J. C. 1985. Immunotoxicity screening of drugs and chemicals: Value of contact hypersensitivity to picryl chloride in the mouse. Meth. Find. Exp. Clin. Pharmacol. 7:303–305.
   PubMedGoogle Scholar
• Dietert, R. R. 2010. Biomarkers of immunotoxicity. In: Biomarkers: In Medicine, Drug Discovery, and Environmental Health (Vaidya, V. S.Bonventre, J. V., Eds.). New York: Wiley, pp. 307–322.
   Google Scholar
• Drolet, B. C., Lorenzi, N. M. 2011. Translational research: Understanding the continuum from bench to bedside. Transl. Med. 157:1–5.
   Google Scholar
• Duramad, P., Holland, N. T. 2011. Biomarkers of immunotoxicity for environmental and public health research. Int. J. Environ. Res. Publ. Health 8:1388–1401.
   PubMed Web of Science ®Google Scholar
• Frawley, R., White, K. Jr., Brown, R., Musgrove, D., Walker, N., Germolec, D. 2011. Gene expression alterations in immune system pathways in the thymus after exposure to immunosuppressive chemicals. Environ. Health Perspect. 119:371–376.
   PubMed Web of Science ®Google Scholar
• Freebern, W. J., Bigwarfe, T. J., Price, K. D., Haggerty, H. G. 2012. Methods: Implementation of in vitro and ex vivo phagocytosis and respiratory burst function assessments in safety testing. J. Immunotoxicol. (submitted).
   Google Scholar
• Friedmann, P. S., Moss, C., Shuster, S., Simpson, J. M. 1983. Quantitative relationships between sensitizing dose of DNCB and reactivity in normal subjects. Clin. Exp. Immunol. 53:709–715.
   PubMed Web of Science ®Google Scholar
• Gennari, A., Ban, M., Braun, A., Casati, S., Corsini, E., Dastych, J., Descotes, J., Hartung, T., Hooghe-Peters, R., House, R., Pallardy, M., Pieters, R., Reid, L., Tryphonas, H., Tschirhart, E., Tuschl, H., Vandebriel, R., Gribaldo, L. 2005. The use of in vitro systems for evaluating immunotoxicity: The report and recommendations of an ECVAM workshop. J. Immunotoxicol. 2:61–83.
   PubMedGoogle Scholar
• Henningsen, G. M., Koller, L. D., Exon, J. H., Talcott, P. A., Osborne, C. A. 1984. A sensitive delayed-type hypersensitivity model in the rat for assessing in vivo cell-mediated immunity. J. Immunol. Meth. 70:153–165.
   PubMed Web of Science ®Google Scholar
• Horand, F., Cretinon, C., Condevaux, F., Descotes, J. 2003. Exploration of the phagocytic activity in rats, monkeys and dogs using two human kits. Toxicol. Sci. 72 (Suppl 1):105 (abstract).
   Google Scholar
• ICH. 2005. ICHS8 Guideline: Immunotoxicity Studies for Human Pharmaceuticals. Available online at: http://www.ich.org/products/guidelines/safety/article/safety-guidelines.html. Accessed on 3 August 2012
   Google Scholar
• ICH. 2011. ICHS6R1 Guideline: Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals. Available online at: http://www.ich.org/products/guidelines/safety/article/safety-guidelines.html. Accessed on 3 August 2012.
   Google Scholar
• Immunotoxicology Technical Committee. 2001. Application of flow cytometry to immunotoxicity testing: summary of a workshop. Toxicology 163:39–48.
   PubMedGoogle Scholar
• ISO. 2006. Principles and Methods for Immunotoxicology Testing of Medical Devices. Technical Specification ISO/TS 10993-20. Geneva: International Organization for Specification.
   Google Scholar
• Kawabata, T. T., Evans, E.W. 2012. Development of immunotoxicity testing strategies for immunomodulatory drugs. Toxicol. Pathol. 40:288–293.
   PubMed Web of Science ®Google Scholar
• Kniker, W. T., Anderson, C. T., Roumiantzeff, M. 1979. The multi-test system: A standardized approach to evaluation of delayed hypersensitivity and cell-mediated immunity. Ann. Allergy 143:73–79.
   Google Scholar
• Krause, M. L., Davis, J. M. 3rd, Knutson, K. L., Strausbauch, M. A., Crowson, C. S., Therneau, T. M., Wettstein, P. J., Matteson, E. L., Gabriel, S. E. 2011. Assessing immune function by profiling cytokine release from stimulated blood leukocytes and the risk of infection in rheumatoid arthritis. Clin. Immunol. 141:67–72.
   PubMedGoogle Scholar
• Ladics, G. S. 2007. Primary immune response to sheep red blood cells (SRBC) as the conventional T-cell dependent antibody response (TDAR) test. J. Immunotoxicol. 4:149–152.
   PubMed Web of Science ®Google Scholar
• Li, Q. 2010. NK cell assays in immunotoxicity testing. Methods Mol. Biol 598:207–219.
   PubMedGoogle Scholar
• Lleo, A., Invernizzi, P., Gao, B., Podda, M., Gershwin, M. E. 2010. Definition of human autoimmunity – autoantibodies versus autoimmune disease. Autoimmun. Rev. 9:A259–266.
   PubMed Web of Science ®Google Scholar
• Luster, M. I., Dean, J. H., Boorman, G. A. 1982. Cell-mediated immunity and its application in toxicology. Environ. Health Perspect. 43:31–36.
   PubMedGoogle Scholar
• Mattes, W. B., and Walker, E. G. 2009. Translational toxicology and the work of the predictive safety testing consortium. Clin. Pharmacol. Ther.. 85:327–330.
   PubMed Web of Science ®Google Scholar
• Millán, O., Urtasun, N., Brunet, M. 2009. Biomarkers of the immunomodulatory effect of immunosuppressive drugs in transplant recipients. Transplant. Rev. 23:120–128.
   Google Scholar
• Miyamoto, T., Taura, Y., Une, S., Yoshitake, M., Nakama, S., Watanabe, S. 1995. Immunological responses to polyvalent canine vaccines in dogs. J. Vet. Med. Sci. 57:347–349.
   PubMedGoogle Scholar
• Morgan, M., Barry, C. A., Donovan, J. L., Sandall, J., Wolfe, C. D., Boaz, A. 2011. Implementing ‘translational’ biomedical research: Convergence and divergence among clinical and basic scientists. Soc. Sci. Med. 73:945–952.
   PubMed Web of Science ®Google Scholar
• National Research Council. 1992. Biologic Markers in Immunotoxicology. Washington, DC: National Academy Press.
   Google Scholar
• Nickel, P., Bestard, O., Volk, H. D., Reinke, P. 2009. Diagnostic value of T-cell monitoring assays in kidney transplantation. Curr. Opin. Organ Transplant. 14:426–431.
   PubMedGoogle Scholar
• Orfila, M. 1815. A General System of Toxicology, or, a Treatise on Poisons, Drawn from the Mineral, Vegetable, and Animal Kingdoms, Considered as to their Relations with Physiology, Pathology and Medical Jurisprudence. Paris: Crochard [English translation freely available online at: books.google.com].
   Google Scholar
• Plitnick, L. M., Herzyk, D. J. 2010. The T-dependent antibody response to keyhole limpet hemocyanin in rodents. Meth. Mol Biol. 598:159–171.
   PubMedGoogle Scholar
• Quah, B.J, and Parish, C. R. 2012. New and improved methods for measuring lymphocyte proliferation in vitro and in vivo using CFSE-like fluorescent dyes. J. Immunol. Meth. 379:1–14.
   PubMed Web of Science ®Google Scholar
• Rubio, D. M., Schoenbaum, E. E., Lee, L. S., Schteingart, D. E., Marantz, P. R., Anderson, K. E., Platt, L. D., Baez, A., Esposito, K. 2010. Defining translational research: Implications for training. Acad. Med. 85:470–475.
   PubMed Web of Science ®Google Scholar
• Shultz, L. D., Ishikawa, F., Greiner, D. L. 2007. Humanized mice in translational biomedical research. Nat. Rev. Immunol. 7:118–130.
   PubMed Web of Science ®Google Scholar
• Straight, J. M., Kipen, H. M., Vogt, R. F., Amler, R. W. 1994. Immune Function Test Batteries for Use in Environmental Health Field Studies. Atlanta, GA: Agency for Toxic Substances and Diseases Registry.
   Google Scholar
• Sung, N. S., Crowley, W. F. Jr., Genel, M., Salber, P., Sandy, L., Sherwood, L. M., Johnson, S. B., Catanese, V., Tilson, H., Getz, K., Larson, E. L., Scheinberg, D., Reece, E. A., Slavkin, H., Dobs, A., Grebb, J., Martinez, R. A., Korn, A., and Rimoin, D. et al. 2003. Central challenges facing the national clinical research enterprise. JAMA 289:1278–1287.
   PubMed Web of Science ®Google Scholar
• Szebeni, J., Muggia, F., Gabizon, A., Barenholz Y. 2011. Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention. Adv. Drug Deliv. Rev. 63:1020–1030.
   PubMed Web of Science ®Google Scholar
• Tarrant, J. M. 2010. Blood cytokines as biomarkers of in vivo toxicity in preclinical safety assessment: Considerations for their use. Toxicol. Sci. 117:4–16.
   PubMed Web of Science ®Google Scholar
• US EPA. 2007. Health Effects Test Guidelines. OPPTS 870.7800: Immunotoxicity. Washington, DC: United States Environmental Protection Agency, Office of Prevention, Pesticides and Toxic Substances, (EPA 712-C-98–351).
   Google Scholar
• van der Kolk, L. E., Grillo-López, A. J., Baars, J. W., Hack, C. E., van Oers, M. H. 2001. Complement activation plays a key role in the side effects of rituximab treatment. Br. J. Hematol. 115:807–811.
   PubMed Web of Science ®Google Scholar
• van Kol, S. W., Hendriksen, P. J., van Loveren, H., Peijnenburg, A. 2012. Transcriptomics analysis of primary mouse thymocytes exposed to bis(tri-n-butyltin)dioxide (TBTO). Toxicology 296:37–47.
   PubMed Web of Science ®Google Scholar
• Verdier, F., Patriarca, C., Descotes, J. 1997. Autoantibodies in conventional toxicity testing. Toxicology 119:51–58.
   PubMed Web of Science ®Google Scholar
• Vos, J. G., van Loveren, H. 1995. Markers for immunotoxic effects in rodents and man. Toxicol. Lett. 82–83:385–394.
   Google Scholar
• Vos, J. G., van Loveren, H. 1999. Experimental studies on immunosuppression: How do they predict for man? Toxicology 129:13–26.
   Google Scholar
• Vos, J. G., van Logten, M. J., Kreeftenberg, J. G., Kruizinga, W. 1979. Hexachlorobenzene-induced stimulation of the humoral immune response in rats. Ann. NY Acad. Sci. 320:535–550.
   PubMedGoogle Scholar
• Walker, M., Makropoulos, D., Achuthanandam, R., Bugelski, P. J. 2010. Recent advances in the understanding of drug-mediated infusion reactions and cytokine release syndrome. Curr Opin. Drug Disc. Devel. 13:124–135.
   PubMedGoogle Scholar
• Weiszhár, Z., Czúcz, J., Révész, C., Rosivall, L., Szebeni, J., Rozsnyay, Z. 2012. Complement activation by poly-ethoxylated pharmaceutical surfactants: Cremophor EL, Tween 80 and Tween 20. Eur. J. Pharm. Sci. 45:492–498.
   PubMed Web of Science ®Google Scholar
• White, K. L. Jr., Sheth, C. M., Peachee, V. L. 2007. Comparison of primary immune responses to SRBC and KLH in rodents. J. Immunotoxicol. 4:153–158.
   PubMed Web of Science ®Google Scholar
• Woolf, S. H. 2008. The meaning of translational research and why it matters. JAMA 299:211–213.
   PubMed Web of Science ®Google Scholar